Sutro Biopharma, Inc.
STRO
$0.8515
-$0.0511-5.66%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -48.49% | -1.60% | 17.51% | -287.39% | 163.03% |
| Total Depreciation and Amortization | 3.84% | 0.50% | 1.65% | 1.73% | -0.46% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 240.01% | -242.34% | -12.19% | 191.46% | -72.26% |
| Change in Net Operating Assets | -121.00% | -114.72% | 391.11% | 23.01% | -676.72% |
| Cash from Operations | -11.19% | -782.35% | 114.60% | -560.07% | 142.00% |
| Capital Expenditure | -28.99% | -9.52% | -69.51% | 69.05% | -339.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -40.21% | 286.03% | -223.34% | 392.46% | 80.59% |
| Cash from Investing | -40.60% | 283.25% | -225.38% | 372.64% | 79.38% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | -30.66% | 0.00% |
| Issuance of Common Stock | -100.00% | -98.87% | 9,289.79% | -- | -100.00% |
| Repurchase of Common Stock | 67.57% | -100.00% | 90.11% | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | -102.36% | -98.95% | 2,913.94% | -9.73% | 45.56% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -81.23% | 227.69% | 729.03% | 67.65% | 91.80% |